Gelstat Corp
OTC:GSAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (13.5), the stock would be worth $0 (100% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0 | $0 |
0%
|
| Industry Average | 13.5 | $0 |
-100%
|
| Country Average | 13.3 | $0 |
-100%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Gelstat Corp
OTC:GSAC
|
1.1m USD | 0 | 0 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
835.2B USD | 48.8 | 39.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.8B USD | 22.1 | 25.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 13.7 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.7B GBP | 19.7 | 28.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
218.2B CHF | 14.3 | 19.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
276.9B USD | 16.6 | 14.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 907.7 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 9.8 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.5B USD | 13 | 19.6 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.2B USD | 8.2 | 16.5 |
Market Distribution
Other Multiples
Gelstat Corp
Glance View
GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Stuart, Florida. The firm is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The firm offers various products, which include GelStat Migraine and GelStat Sleep. GelStat Migraine is a solution designed for the pain relief from migraine headaches. GelStat Migraine is a formulation based on the medicinal plant’s feverfew (tanacetum parthenium) and ginger (zingiber officinale). Feverfew and ginger contain various compounds, including sesquiterpene lactones and flavonoids. GelStat Sleep provides relief from sleep disorders and its associated symptoms.
